Concepedia

Lawrence Lehrner

LL

4

Publications

168

Citations

4

H-Index

2014

Active since

Affiliations

Stanford University(Current)

The University of Sydney

Center for Clinical Research (United States)

Kidney Associates

Lawrence Lehrner is an author at Stanford University specializing in chronic kidney disease, atherosclerosis, and urology.

Top concepts

Publications per year

2014–2023

4

Publications

4

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 111 citations · Full text

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

Tae Won Yi, Brendan Smyth, Gian Luca Di Tanna et al. · American Journal of Kidney Diseases · 2023 · 25 citations · Full text

, , +10

Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease

Matthias Girndt, Patricia Houser, Roberto Manllo-Karim et al. · Vaccine · 2023 · 19 citations · Full text

A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis

Stuart J. Murray, Lawrence Lehrner, Fahd Al-Saghir et al. · International Journal of Nephrology and Renovascular Disease · 2014 · 13 citations · Full text

Rows per page

1–4 of 4